JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, published by the Endocrine Society, stands as a premier academic journal within the field of endocrinology, diabetes, and metabolism. With a legacy spanning from 1941 to 2024, this journal is distinguished by its significant impact factor, ranking in the Q1 category across multiple related disciplines including biochemistry, clinical biochemistry, and medicine. This esteemed journal, ISSN 0021-972X and E-ISSN 1945-7197, is backed by rigorous peer review, ensuring the publication of high-quality research that contributes to the advancement of clinical practices and scientific knowledge. With a commendable Scopus ranking, positioned in the top percentile of multiple categories, JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM serves as an essential resource for researchers, professionals, and students who seek to stay informed about the latest findings and innovations in endocrine research. The journal enriches the existing body of knowledge and fosters discussion among scholars and practitioners alike, solidifying its crucial role in the ongoing discourse in endocrinology and metabolic health.

CLINICAL NUTRITION, published by Churchill Livingstone, is a premier international journal dedicated to advancing the field of nutrition and dietetics, as well as critical care and intensive care medicine. Established in 1982, the journal has consistently delivered high-quality, peer-reviewed research, celebrated for its impact with an impressive Q1 ranking in both Critical Care and Intensive Care Medicine and Nutrition and Dietetics categories as of 2023. With its emphasis on collaborative discourse among researchers, clinicians, and educators, CLINICAL NUTRITION plays a crucial role in shaping dietary practices and interventions that enhance patient care and recovery. Although the journal does not provide open access, its rigorously curated content remains a vital resource for professionals seeking to implement evidence-based nutrition strategies in clinical settings. The journal is situated in the United States, with operations based out of Edinburgh, Scotland. Researchers are encouraged to engage with this influential publication to stay abreast of the latest findings and innovations within these intersecting fields.

DIABETES & METABOLISM, published by MASSON EDITEUR in France, is a leading academic journal dedicated to the fields of endocrinology, diabetes, and metabolism. With an impressive Impact Factor reflecting its esteemed reputation, the journal has been ranked in the Q1 category across multiple disciplines including Endocrinology, Internal Medicine, and more, showcasing its significance and influence in the scientific community. Since its inception in 1996 and continuing its contributions through 2024, DIABETES & METABOLISM systematically disseminates high-quality research findings, reviews, and clinical studies aimed at furthering knowledge and encouraging innovation in metabolic diseases. Although not an open-access journal, it ensures that valuable research is accessible to a broad audience through institutional subscriptions and affiliations. As a key resource for researchers, clinicians, and students alike, this journal stands at the forefront of advancing understanding and treatment options in diabetes and related metabolic disorders, making it an essential addition to any academic library.

Nutrition Clinique et Metabolisme is a pivotal journal dedicated to the fields of endocrinology, diabetes, metabolism, and nutrition. Published by MASSON EDITEUR in France, this journal has been a prominent platform for disseminating research findings since its establishment in 1987, with an ongoing commitment to the academic community through its latest publication efforts through 2024. Though indexed in the Q4 quartile across several categories, including Endocrinology, Diabetes and Metabolism, and Nutrition and Dietetics, it continues to play an essential role in advancing knowledge in these vital areas of health. Despite the absence of open-access options, the journal provides valuable insights for researchers, clinicians, and students alike, fostering a deeper understanding of the complex interactions between nutrition and metabolic processes. With its ISSN 0985-0562 and E-ISSN 1768-3092, Nutrition Clinique et Metabolisme stands as a respected source of information aimed at improving health outcomes through rigorous scientific inquiry.

European Journal of Nutrition, published by Springer Heidelberg, is a premier outlet for groundbreaking research in the field of nutrition and dietetics. Established in 1996 and set to continue its impactful legacy until at least 2024, this journal enjoys an impressive recognition, holding a Q1 category rank in both Medicine (miscellaneous) and Nutrition and Dietetics, with notable Scopus rankings that place it in the top 10% of its field. The journal facilitates open access options, enhancing the dissemination of knowledge across the globe. It serves as a vital platform for researchers, healthcare professionals, and students, promoting the exchange of innovative ideas and advancements in nutritional science that aim to improve health outcomes worldwide. With a commitment to quality and relevance, the European Journal of Nutrition continues to shape the future of nutrition research and practice.

DIABETES OBESITY & METABOLISM, published by Wiley, is a premier international journal dedicated to the fields of endocrinology, diabetes, and metabolic disorders. With an impressive impact factor and its status as a Q1 journal in multiple categories—including Endocrinology and Internal Medicine—this publication is highly regarded in the academic community. Since its inception in 1999, the journal has served as a crucial platform for the dissemination of cutting-edge research, reviews, and clinical studies, driving advancements in understanding and treatment of diabetes and obesity. Researchers and professionals alike benefit from its rigorous peer-review process and extensive reach, as it aims to bridge the gap between laboratory findings and clinical applications. Although not an Open Access journal, articles are accessible through institutional subscriptions, ensuring that vital knowledge reaches those committed to enhancing patient care and expanding the scientific body of work in these pivotal areas.

Clinical Nutrition ESPEN is a distinguished journal published by ELSEVIER, focusing on the critical intersection of clinical nutrition and metabolic health. With an ISSN of 2405-4577, this journal serves as an essential resource for researchers, practitioners, and students in the fields of Endocrinology, Diabetes and Metabolism as well as Nutrition and Dietetics. Operating out of the United Kingdom, it has garnered a respectable Q2 ranking in both categories for 2023, indicating its significant impact and relevance in the field. Although it does not follow an open access model, the journal offers valuable insights into contemporary nutrition research, clinical practices, and dietary interventions, making it a vital tool for those committed to improving patient outcomes through nutritional science. In its evolving journey, covering work from 2015 to 2024, Clinical Nutrition ESPEN continues to shape the dialogue in nutrition research, addressing pressing health challenges and fostering innovation in dietetic practice.

Diabetes Stoffwechsel und Herz, published by VERLAG KIRCHHEIM, is a distinguished journal that focuses on the interdisciplinary field of diabetes research, cardiology, and metabolic disorders. With its dedicated approach, the journal aims to disseminate cutting-edge findings and foster innovative discussions among researchers and practitioners in the healthcare community. Despite its discontinuation in Scopus coverage since 2017, the journal continues to hold significance in advancing knowledge regarding the intricate relationship between diabetes and cardiovascular health. It offers researchers a platform to explore the biochemical, genetic, and clinical aspects of endocrinology, while also catering to the needs of professionals aiming to apply the latest research in their practice. The journal’s rankings, which place it in the lower percentiles across various relevant categories, reflect a unique opportunity for contributors looking to impact a niche yet vital area of medicine. As the field evolves, Diabetes Stoffwechsel und Herz remains committed to enriching the dialogue surrounding these critical health issues.

NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES, published by Elsevier Science Ltd, is a prestigious academic journal dedicated to advancing the knowledge and understanding of the intricate relationships between nutrition, metabolism, and cardiovascular health. With an impressive HIndex and a consistent trajectory of high-impact research, this journal occupies a commendable position in the academic landscape, achieving Q1 rankings in both Cardiology and Cardiovascular Medicine, as well as in Nutrition and Dietetics for the year 2023. The journal’s Scopus rankings further solidify its reputation, occupying top percentiles across various categories, making it an essential resource for researchers, healthcare professionals, and students keen on exploring the latest findings in the field. Although it is not an open access journal, readers can access a wealth of knowledge that spans from 1996 to 2024, with articles that cover diverse topics in endocrinology, diabetes, and metabolism. By disseminating groundbreaking research and reviews, NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES aims to foster innovation and evidence-based practices that contribute to improved health outcomes worldwide.

Diabetologie und Stoffwechsel is a prominent academic journal specializing in the fields of endocrinology, diabetes, and metabolism, published by GEORG THIEME VERLAG KG. Since its inception in 2006, this German journal has strived to disseminate cutting-edge research and innovative findings that advance the understanding of metabolic disorders and the management of diabetes. With an ISSN of 1861-9002 and an E-ISSN of 1861-9010, it caters to a diverse audience ranging from researchers to healthcare professionals and students in the medical field. While it currently holds a Q4 ranking in the 2023 Scopus quartiles for its area, the journal serves as a critical platform for emerging insights and discussions impacting diabetes care and research, fostering collaboration and knowledge-sharing in a rapidly evolving landscape. The convergence of its coverage until 2024 signifies a commitment to ongoing exploration into the complexities of metabolic health, making it a valuable resource for anyone passionate about these vital areas of health.